Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of advanced hepatocellular carcinoma: beyond sorafenib.

× No keyword cloud information.

11 in total

1. Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents.

Authors: Ying-Qi Feng; Bo-An Li; Fan Feng; Yong-Shou Chen; Yi-Xin Ren; Heng Zhang; Shuang Cao
Journal: Onco Targets Ther Date: 2020-07-27 Impact factor: 4.147

Review 2. Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies.

Authors: Huijuan Cheng; Guodong Sun; Hao Chen; Yu Li; Zhijian Han; Yangbing Li; Peng Zhang; Luxi Yang; Yumin Li
Journal: Am J Cancer Res Date: 2019-08-01 Impact factor: 6.166

3. Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem.

Authors: Yanling Liu; Manman Tan; Yujuan Zhang; Wei Huang; Liangliang Min; Shanshan Peng; Keng Yuan; Li Qiu; Weiping Min
Journal: Nanoscale Res Lett Date: 2020-05-24 Impact factor: 4.703

Review 4. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma.

Authors: Fang Huang; Bing-Rong Wang; Yi-Gang Wang
Journal: World J Gastroenterol Date: 2018-11-07 Impact factor: 5.742

5. Alternative treatment strategies to sorafenib in patients with advanced hepatocellular carcinoma: a meta-analysis of randomized Phase III trials.

Authors: Hui Wang; Hefang Wang; Zhichong Yu; Honghao Liu
Journal: Onco Targets Ther Date: 2018-08-27 Impact factor: 4.147

6. MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents.

Authors: Bin Yang; Chunping Wang; Hui Xie; Yiwu Wang; Jiagan Huang; Yihui Rong; Huixin Zhang; Huifang Kong; Yongping Yang; Yinying Lu
Journal: Cell Death Dis Date: 2019-10-14 Impact factor: 8.469

7. SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma.

Authors: Zuyi Ma; Zhenchong Li; Shujie Wang; Qi Zhou; Zuguang Ma; Chunsheng Liu; Bowen Huang; Zehao Zheng; LinLing Yang; Yiping Zou; Chuanzhao Zhang; Shanzhou Huang; Baohua Hou
Journal: J Hepatocell Carcinoma Date: 2021-08-07

Review 8. Emerging therapies in advanced hepatocellular carcinoma.

Authors: Sowmini Medavaram; Yue Zhang
Journal: Exp Hematol Oncol Date: 2018-08-03

9. Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.

Authors: Shanzhou Huang; Chuanzhao Zhang; Chengjun Sun; Yuchen Hou; Yixi Zhang; Nga Lei Tam; Zekang Wang; Jia Yu; Bowen Huang; Hongkai Zhuang; Zixuan Zhou; Zuyi Ma; Zhonghai Sun; Xiaoshun He; Qi Zhou; Baohua Hou; Linwei Wu
Journal: Aging (Albany NY) Date: 2020-02-11 Impact factor: 5.682

10. Systemic characterization of the SLC family genes reveals SLC26A6 as a novel oncogene in hepatocellular carcinoma.

Authors: Jianzhong Cao; Penghui Wang; Jiemin Chen; Xiaodong He
Journal: Transl Cancer Res Date: 2021-06 Impact factor: 1.241